Inhalation

INH0422

Issue link: https://www.e-digitaleditions.com/i/1463386

Contents of this Issue

Navigation

Page 33 of 42

This section provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No endorsement or preference is intended. 32 APRIL 2022 Inhalation EXTRA FOCUS Product Development This section of Inhalation provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No product endorsement or preference is intended. Inhaled drug delivery services Vectura has more than 20 years' of experience in help- ing customers bring inhaled medicines to the market. ey can integrate formulation, device and develop- ment services to accelerate inhaled products through the phases of drug development. With a range of technology platforms, including dry powder inhalers (DPIs), pressurized metered dose inhalers (pMDIs), and smart nebulizers, Vectura o ers exibility and expertise to support programs from pre-clinical for- mulation optimization and device selection through scale-up, GMP product and device manufacturing. Vectura UK: +44 1249 667700 info@vectura.com www.vectura.com DPI development and manufacturing services Experic's experienced team provides customized and scalable lling, packaging and logistics solutions at clinical- and commercial-scale for reservoir and single- dose dry powder inhalation devices. From early devel- opment and manufacturing for any single dose unit, to clinical trial supplies and logistics, Experic o ers services that can solve dry powder inhaler (DPI) man- ufacturing challenges, accelerate time to market, and mitigate risk for products with a range of properties, particle sizes, doses and throughput requirements. Experic LLC US: +1 609 537-4040 www.expericservices.com Integrated DPI development services Lonza Small Molecules provides integrated dry pow- der inhaler (DPI) development services to advance molecules, drawing on 25 years of experience in par- ticle engineering, formulation design and encapsu- lation techniques. Our premier particle engineering technologies services, utilizing both jet milling and spray drying, are tailored to your molecule, target product pro le and delivery device. Dedicated DPI formulation, analytical and manufacturing teams ensure that development timelines are met while min- imizing program risk and complexity. Lonza Small Molecules US: +1 541 382-4100 www.pharma.lonza.com

Articles in this issue

Links on this page

view archives of Inhalation - INH0422